Amgen (4332) Stock Forecast & Price Target
4332 Analyst Ratings
Moderate Buy
9Buy16Hold2Sell
Based on 27 analysts giving stock ratings to Amgen in the past 3 months
4332 Stock 12 Month Forecast
Average Price Target
HKD 3,190.77▲(1724640.65% Upside)Based on 27 Wall Street analysts offering 12 month price targets for Amgen in the last 3 months. The average price target is HKD 3,190.77 with a high forecast of HKD 3,922.68 and a low forecast of HKD 1,804.43. The average price target represents a 1724640.65% change from the last price of HKD 0.19.
Past 12 Months12 Month ForecastDec2025Sep2026
HighHKD 3.92K
AverageHKD 3.19K
LowHKD 1.8K
Highest Price TargetHighestHKD 3,922.68Average Price TargetHKD 3,190.77Lowest Price TargetLowestHKD 1,804.43
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Geoff Meacham | Citi | HKD 3,177.37 | hold | 1717396.07%Upside | Reiterated | 10/27/26 | ||
| Luca Issi | RBC Capital | HKD 3,373.50 | buy | 1823414.34%Upside | Reiterated | 10/27/26 | ||
| Mohit Bansal | Wells Fargo | HKD 3,373.50 | hold | 1823414.34%Upside | Reiterated | 10/27/26 | ||
| Emily Field | Barclays | HKD 3,138.14 | hold | 1696192.41%Upside | Reiterated | 10/26/26 | ||
| Tazeen Ahmad | Bank of America Securities | HKD 2,573.28 | sell | 1390859.78%Upside | Reiterated | 10/26/26 | ||
| David Amsellem | Piper Sandler | HKD 3,585.33 | buy | 1937914.08%Upside | Reiterated | 10/26/26 | ||
| Yaron Werber | TD Cowen | HKD 3,546.10 | buy | 1916710.43%Upside | Reiterated | 10/26/26 | ||
| Louise Chen | Scotiabank | HKD 3,922.68 | buy | 2120265.52%Upside | Reiterated | 10/26/26 | ||
| Courtney Breen | Bernstein | HKD 2,706.65 | hold | 1462952.21%Upside | Reiterated | 10/25/26 | ||
| Salveen Richter | Goldman Sachs | HKD 3,530.41→HKD 3,773.61 | buy | 2039691.63%Upside | Reiterated | 10/25/26 | ||
| Michael Yee | UBS | HKD 3,687.32 | buy | 1993043.59%Upside | Reiterated | 10/24/26 | ||
| Jay Olson | Oppenheimer | HKD 3,530.41→HKD 3,765.77 | buy | 2035450.90%Upside | Assigned | 10/23/26 | ||
| Evan Seigerman | BMO Capital | HKD 3,530.41→HKD 3,255.82 | hold | 1759803.38%Upside | Reiterated | 10/12/26 | ||
| Vamil Divan | Guggenheim | HKD 3,044.00→HKD 2,965.54 | hold | 1602896.33%Upside | Reiterated | 10/12/26 | ||
| Carter Gould | Cantor Fitzgerald | HKD 3,138.14→HKD 3,451.96 | hold | 1865821.65%Upside | Assigned | 10/08/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Geoff Meacham | 10/27/26 | HKD 3,177.37 | hold | 1717396.07%Upside | Reiterated | Citi | ||
| Luca Issi | 10/27/26 | HKD 3,373.50 | buy | 1823414.34%Upside | Reiterated | RBC Capital | ||
| Mohit Bansal | 10/27/26 | HKD 3,373.50 | hold | 1823414.34%Upside | Reiterated | Wells Fargo | ||
| Emily Field | 10/26/26 | HKD 3,138.14 | hold | 1696192.41%Upside | Reiterated | Barclays | ||
| Tazeen Ahmad | 10/26/26 | HKD 2,573.28 | sell | 1390859.78%Upside | Reiterated | Bank of America Securities | ||
| David Amsellem | 10/26/26 | HKD 3,585.33 | buy | 1937914.08%Upside | Reiterated | Piper Sandler | ||
| Yaron Werber | 10/26/26 | HKD 3,546.10 | buy | 1916710.43%Upside | Reiterated | TD Cowen | ||
| Louise Chen | 10/26/26 | HKD 3,922.68 | buy | 2120265.52%Upside | Reiterated | Scotiabank | ||
| Courtney Breen | 10/25/26 | HKD 2,706.65 | hold | 1462952.21%Upside | Reiterated | Bernstein | ||
| Salveen Richter | 10/25/26 | HKD 3,530.41→HKD 3,773.61 | buy | 2039691.63%Upside | Reiterated | Goldman Sachs | ||
| Michael Yee | 10/24/26 | HKD 3,687.32 | buy | 1993043.59%Upside | Reiterated | UBS | ||
| Jay Olson | 10/23/26 | HKD 3,530.41→HKD 3,765.77 | buy | 2035450.90%Upside | Assigned | Oppenheimer | ||
| Evan Seigerman | 10/12/26 | HKD 3,530.41→HKD 3,255.82 | hold | 1759803.38%Upside | Reiterated | BMO Capital | ||
| Vamil Divan | 10/12/26 | HKD 3,044.00→HKD 2,965.54 | hold | 1602896.33%Upside | Reiterated | Guggenheim | ||
| Carter Gould | 10/08/26 | HKD 3,138.14→HKD 3,451.96 | hold | 1865821.65%Upside | Assigned | Cantor Fitzgerald |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Amgen
3 Months
Success Rate16/21 ratings generated profit
76%
Average Return
+6.48%
Copying David Amsellem's trades and holding each position for 3 Months would result in 76.19% of your transactions generating a profit, with an average return of +6.48% per trade.
1 Year
Success Rate21/21 ratings generated profit
100%
Average Return
+27.02%
Copying David Amsellem's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +27.02% per trade.
2 Years
Success Rate21/21 ratings generated profit
100%
Average Return
+40.60%
Copying David Amsellem's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +40.60% per trade.
4332 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 26 | 19 | 24 | 34 | 41 |
| Hold | 27 | 22 | 26 | 39 | 47 |
| Sell | 2 | 2 | 3 | 5 | 6 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 55 | 43 | 53 | 78 | 94 |
In the current month, 4332 has received 41 Buy Ratings, 47 Hold Ratings, and 6 Sell Ratings. 4332 average Analyst price target in the past 3 months is 3,190.77.
4332 Financial Forecast
HighHKD 47.78
ConsensusHKD 45.40
LowHKD 42.92
4332 Earnings Forecast
Next quarter’s earnings estimate for 4332 is HKD 45.40 with a range of HKD 42.92 to HKD 47.78. The previous quarter’s EPS was HKD 49.35. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighHKD 80.6B
ConsensusHKD 79B
LowHKD 77.3B
4332 Sales Forecast
Next quarter’s sales forecast for 4332 is HKD 78.99B with a range of HKD 77.26B to HKD 80.64B. The previous quarter’s sales results were HKD 78.98B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
4332 Stock Forecast FAQ
What is HK:4332’s average 12-month price target, according to analysts?
Based on analyst ratings, Amgen’s 12-month average price target is HK$3,190.77.
What is HK:4332’s upside potential, based on the analysts’ average price target?
Amgen has 1724640.65% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Amgen a Buy, Sell or Hold?
Amgen has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 16 hold ratings and 2 sell ratings.
What is Amgen’s share price target?
The average share price target for Amgen is HK$3,190.77. This is based on 27 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is HK$3,922.68, and the lowest forecast is HK$1,804.43. The average share price target represents a 1724640.65% increase from the current price of HK$0.185.
What do analysts say about Amgen?
Amgen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 27 Wall Street analysts.
How can I buy shares of Amgen?
To buy shares of HK:4332, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.